Filing Details

Accession Number:
0001127602-15-017122
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-05-13 16:27:01
Reporting Period:
2015-05-11
Filing Date:
2015-05-13
Accepted Time:
2015-05-13 16:27:01
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1145197 Insulet Corp PODD Surgical & Medical Instruments & Apparatus (3841) 043523891
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1395783 Anthony R Diehl C/o Insulet Corporation
600 Technology Park Drive, Suite 200
Billerica MA 01821
Secretary And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-05-11 12,500 $26.63 30,837 No 4 S Direct
Common Stock Acquisiton 2015-05-11 4,482 $15.09 35,319 No 4 M Direct
Common Stock Acquisiton 2015-05-11 5,535 $15.16 40,854 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 M Direct
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-05-11 4,482 $0.00 4,482 $15.09
Common Stock Employee Stock Option (Right to Buy) Disposition 2015-05-11 5,535 $0.00 5,535 $15.16
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2018-03-12 No 4 M Direct
0 2020-03-01 No 4 M Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 24, 2014.
  2. The price reported represents the weighted average sale price of the shares sold. The shares were sold at varying prices in the range of $26.35 to $27.50. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities Exchange Commission, the Issuer or a security holder of the Issuer, to provide full informaiton regarding the number of shares sold at each separate price.
  3. Includes 5,000 restricted stock units granted on April 1, 2012 which vest on April 1, 2016; 6,250 restricted stock units granted on March 1, 2013 which vest one-half of the total units on March 1, 2016 and one-half of the total units on March 1, 2017; 4,000 performance share units granted on March 1, 2013, which vest on March 1, 2016; 5,334 restricted stock units granted on March 3, 2014 which vest one-half of the total units on March 3, 2016, and one-half of the total units on March 3, 2017; and 10,253 restricted stock units granted on March 2, 2015, which vest one-third of the total units on March 2, 2016, one-third of the total units on March 2, 2017 and one-third of the total units on March 2, 2018. Vested shares will be delivered to the reporting person as soon as practicable following a vesting date.
  4. Includes an aggregate of 1,249 shares acquired under the Insulet Corporation 2007 Employee Stock Purchase Plan on the following dates: 400 shares acquired on December 31, 2007; and 849 shares acquired on June 30, 2008.
  5. This option is subject to a four-year vesting period, with 25% of the total award vesting one year after the grant date and the remainder vesting in equal quarterly installments each quarter thereafter for 12 quarters, subject to continued employment.